Stay informed with the latest litigation news. Explore now

IP Verse

Takeda competitive analysis

Latest publications and patents of Takeda New

Explore the latest publications and patents granted to Takeda, showcasing their recent innovations and technological advancements.

Last updated on: Sep 11, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Takeda

EP3518933
Feb 26, 2025Methods Of Treating Uterine Fibroids And EndometriosisPatent Maintained As Amended
EP3518932
Nov 13, 2024Treatment Of Prostate CancerGranted And Under Opposition
EP2300013
Nov 13, 2024Phosphorous Derivatives As Kinase InhibitorsPatent Maintained As Amended
EP3782986
Jul 10, 2024Heterocyclic CompoundGranted And Under Opposition
EP3237004
May 8, 2024Predicting Outcome Of Treatment With An Anti- 4 7 Integrin AntibodyGranted And Under Opposition
EP3370729
Sep 27, 2023Methods For The Identification, Evaluation And Treatment Of Patients Having Multiple MyelomaRevoked
EP3263110
May 10, 2023Solid PreparationGranted And Under Opposition
EP3521422
Oct 6, 2021Substantially Animal Protein-Free Recombinat Furin And Methods For Producing SameGranted And Under Opposition
EP3626258
Aug 4, 2021Methods And Compositions For Cns Delivery Of Iduronate-2-SulfataseGranted And Under Opposition
EP3103469
Dec 9, 2020Cns Delivery Of Therapeutic AgentsGranted And Under Opposition

Latest oppositions filed by Takeda

Explore patent oppositions filed by Takeda against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 18, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3481415
Stable Liquid FibrinogenLABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIESJun 5, 2024
EP3679915
Flavivirus VaccinesSANOFI PASTEURJan 20, 2023
EP3377103
Functional Antibody Fragment Complementation For A Two-Components System For Redirected Killing Of Unwanted CellsREVITOPEDec 17, 2021
EP3071596
Improved Process For The Preparation Of Immunoglobulin G (Igg)BIO PRODUCTS LABORATORYMay 29, 2019
EP2345425
Immunoglobulin G (Igg) Concentrate Depleted Of Anti-A And Anti-B Antibodies And Of Polyreactive IggsLABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIESApr 11, 2019

Latest patents of Takeda opposed by its competitors

Explore Takeda's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 18, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3518933
Feb 26, 2025Methods Of Treating Uterine Fibroids And Endometriosis1
EP2300013
Nov 13, 2024Phosphorous Derivatives As Kinase Inhibitors1
EP3518932
Nov 13, 2024Treatment Of Prostate Cancer2
EP3782986
Jul 10, 2024Heterocyclic Compound1
EP3237004
May 8, 2024Predicting Outcome Of Treatment With An Anti- 4 7 Integrin Antibody1
EP3370729
Sep 27, 2023Methods For The Identification, Evaluation And Treatment Of Patients Having Multiple Myeloma1
EP3263110
May 10, 2023Solid Preparation1
EP3521422
Oct 6, 2021Substantially Animal Protein-Free Recombinat Furin And Methods For Producing Same1
EP3626258
Aug 4, 2021Methods And Compositions For Cns Delivery Of Iduronate-2-Sulfatase1
EP3103469
Dec 9, 2020Cns Delivery Of Therapeutic Agents1

Latest PTAB cases involving Takeda New

Discover the latest PTAB cases involving Takeda, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 17, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Takeda

IPR2025-00776Mar 31, 2025VALNEVA AUSTRIATAKEDA VACCINESPending
IPR2023-00354Dec 27, 2022TAKEDA VACCINESVALNEVA AUSTRIAInstitution Denied
IPR2015-00754Feb 17, 2015ARRAY BIOPHARMATAKEDA PHARMACEUTICALFinal Written Decision

Top competitors of Takeda

Top competitors of Takeda based on patent oppositions.